Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

870367.pdf (738.66 KB)

Document type

Article

Version

Published version

Publication date

2023-07-17

Publication license

cc-by (c) Peñuelas-Haro, I. et al., 2023
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/217250

A novel empeROR of pancreatic malignancy

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.15252/embj.2023114282

Abstract

How pancreatic cancer cells acquire tumor initiating capacities remains poorly understood. A recent study by Yamazaki et al (2023) uncovers a crucial, targetable role of tyrosine kinase-like orphan receptor (ROR1) in PDAC tumor formation and progression.

Subject

Càncer de pàncrees, Receptors cel·lulars, Cèl·lules canceroses, Diagnòstic molecular

Subject (English)

Pancreas cancer, Cell receptors, Cancer cells, Molecular diagnosis

Citation

Collections

Articles publicats en revistes (Patologia i Terapèutica Experimental)

Citation

PEÑUELAS HARO, Irene and ESPINET, Elisa. A novel empeROR of pancreatic malignancy. The EMBO Journal. 2023. Vol. 42, num. 14. ISSN 0261-4189. [consulted: 11 of August of 2026]. Available at: https://hdl.handle.net/2445/217250

Export metadata

JSON - METS

Share record